Overview

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The study was a three-arm, active-control, multi-centre, parallel group study.
Phase:
Phase 3
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Leuprolide